Explore Our Publications

At Magnolia Innovation, we are constantly striving to contribute meaningful data and analysis to the larger healthcare conversation.

Below are some of the independent and collaborative publications we have worked on recently.

Patient- and Caregiver-Reported Quality of Life and Burden of Disease in Wiskott-Aldrich Syndrome: Findings from a Multinational Survey

This multinational study aims to quantify both the caregiver and patient-related burdens of WAS and add to the existing literature by examining various domains of health-related QoL including symptom burden, transplant burden, time investment, social and emotional well-being, and professional status

Patient- and Caregiver-Reported Quality of Life and Burden of Disease in Wiskott-Aldrich Syndrome: Findings from a Multinational Survey

This multinational study aims to quantify both the caregiver and patient-related burdens of WAS and add to the existing literature by examining various domains of health-related QoL including symptom burden, transplant burden, time investment, social and emotional well-being, and professional status

The Broadsword and the Scalpel: Perspectives on Market Research in the Age of ChatGPT

What role can ChatGPT and its competitors play in market research?

broadsword and scalpel cover

BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs

Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website

BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs

Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website

Academic Execs Share How Pharma Should Engage With Oncology Customers

Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma

Academic Execs Share How Pharma Should Engage With Oncology Customers

Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma

Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers

The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers

Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers

The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers

Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy

How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients

Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy

How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients

An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy

How MLD Caregivers Lives are Negatively Affected By the Burden of care

An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy

How MLD Caregivers Lives are Negatively Affected By the Burden of care

C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?

A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact 

C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?

A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact 

Stress, Inflammation, and Suboptimal Treatment Outcomes

psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact. 

Stress, Inflammation, and Suboptimal Treatment Outcomes

psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact. 

Researching, Recognizing, and Reaching the Rare

Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs 

Researching, Recognizing, and Reaching the Rare

Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs 

Many Vendors or One Partner?

Read how a small biopharma company relied on a single vendor to launch a market-leading drug.

oncologist segmentation cover

Many Vendors Or One Partner?

Read how a small biopharma company relied on a single vendor to launch a market-leading drug.

oncologist segmentation cover

COVID-19: Impact on the Rare Disease Community

Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic

COVID-19: Impact on the Rare Disease Community

Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic

Oncologist Segmentation

Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists

Oncologist Segmentation

Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists

Benchmarking the COVID-19 Pandemic

Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic

Benchmarking the COVID-19 Pandemic

Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic

The Hidden Burden

Optimize commercial efforts by understanding the common challenges in the rare disease landscape

The Hidden Burden

Optimize commercial efforts by understanding the common challenges in the rare disease landscape

Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)

Understand the Debilitating effects of ph1 to identify the opportunities for Easier diagnosis and effective therapies

Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)

Understanding the Debilitating effects of Ph1 to identify the Opportunities for Easier diagnosis and effective therapies

understanding the burden of primary hyperoxaluria type 1 (ph1)